By Wendy Sarubbi | November 2, 2023 5:01 pm

The U.S. National Science Foundation has awarded a Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) Phase II award for $1 million to Kismet Technologies to further its research and development of a broad-spectrum residual antimicrobial technology that eradicates COVID-19 among other bacteria and viruses.

From left, Drs. Parks, Seal and Coathup.

The company, led by UCF materials science and engineering alumna Christina Drake ’07PhD, is working with a multidisciplinary team of UCF researchers, including Burnett School of Biomedical Sciences Director Griff Parks, College of Medicine Professor Melanie Coathup and Department of Materials Science and Engineering Chair Sudipta Seal, to further research the residual antimicrobial technology.  Kismet Technologies is one of 10 recipients of the STTR award this year.

During phase I testing, the team proved the antimicrobial technology could kill COVID-19 and other serious viruses such as parainfluenza and Zika.

Link to full story:

Post Tags

Related Stories